Why Wegovy’s Parent Company Cut Ties With Hims & Hers, Sending Shares Tumbling
Hims & Hers Stock Plummets as Novo Nordisk Ends Wegovy Partnership Over Safety Concerns Hims & Hers Health Inc. (HIMS) saw its shares crash nearly 30% on Monday after Novo Nordisk, the pharmaceutical giant behind the popular weight-loss drug Wegovy, abruptly terminated its partnership with the telehealth company. In a statement, Novo Nordisk cited concerns…